Study of effect of Ayurvedic drug, Kantakari Avaleha in Cough of children.
Phase 2
- Conditions
- Health Condition 1: R05- Cough
- Registration Number
- CTRI/2022/12/047978
- Lead Sponsor
- ttarakhand Ayurved University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Patients between the age group of 5-16 years irrespective of gender
2 Primarily the patients will be selected on the basis of the presence of classical
symptomatology of Kaphaja Kasa.
Exclusion Criteria
1 Children below 5 years or above 16 years will be excluded
2 Patient presenting with symptoms other than Kaphaja Kasa
3 Patient present with pneumonia chronic obstructive pulmonary disease (COPD)
Emphysema Diphtheria Asthma pertussis or congenital anomalies
4 Patient associated with systemic illness such as Tuberculosis HIV and other chronic
debilitating disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relife in Subjective parameters like <br/ ><br>1 Kasa (cough) <br/ ><br>2 Kaphanishthivana (expectoration) <br/ ><br>3 Aruchi (anorexia) <br/ ><br>4 Peenus (rhinorrhea) <br/ ><br>5 Mandagni (loss of appetite) <br/ ><br>6 Shirashoola (Headache) <br/ ><br>7 Chardi (vomiting)Timepoint: 1st 7th 14th days
- Secondary Outcome Measures
Name Time Method Relife in Objective parameters like <br/ ><br>Routine Blood Examinations ( HB TLC DLC ESR) <br/ ><br> AEC (Absolute Eosinophil Count) <br/ ><br> Montoux teat for exclusion if necessary <br/ ><br> X- ray of chest if necessaryTimepoint: 14th days